Skip to content

Research on an Intelligent Chronic Disease Comorbidity and Wellness Recommendation System Integrating Traditional Chinese Medicine Constitution Database with Multimodal Large Language Models

Research on an Intelligent Chronic Disease Comorbidity and Wellness Recommendation System Integrating Traditional Chinese Medicine Constitution Database with Multimodal Large Language Models

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113269
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with comorbidities of hypertension, hyperglycemia, and/or hyperlipidemia

Interventions

Experimental group:Universal AI-HEALS
Control group:General Management Team
Experimental group:Precision AI-HEALS intervention group based on constitution identification

Sponsors

The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.a clear diagnosis of hypertension, type 2 diabetes, and hyperlipidemia, requiring patients with comorbidities of any two of these diseases; 3.stable condition with no recent acute complications; 4.capable of completing questionnaires, providing informed consent, and voluntarily participating in the study.

Exclusion criteria

Exclusion criteria: 1.Individuals with other major diseases that may affect the assessment of physical constitution or the implementation of interventions, such as malignant tumors, severe liver or kidney dysfunction, active tuberculosis, psychiatric disorders, etc. 2.those who have recently (within one month) received systematic traditional Chinese medicine treatment (herbal decoctions or acupuncture) that may affect the initial assessment of constitution type; 3.pregnant or breastfeeding women; 4.participants in other interventional clinical studies.

Design outcomes

Primary

MeasureTime frame
HbA1c;Blood pressure;LDC-C;Fasting blood glucose;

Secondary

MeasureTime frame
CDSMS;CCMQ-30;patient health questionnaire-4,PHQ-4;Satisfaction;

Countries

China

Contacts

Public ContactYibo Wu

The Fourth Affiliated Hospital, Zhejiang University School of Medicine

bjmcwuyibo@outlook.com+86 579 8993 5056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026